Dr. Brad Wong is the founder and president of Mettalytics, and an affiliated researcher at the Bergen Centre for Ethics and Priority Setting in Health, at the University of Bergen, Norway. Brad is a global expert in cost-benefit and social return-on-investment analysis of international development interventions, having overseen or contributed to hundreds of economic evaluations in low-and-middle-income countries. He has published peer reviewed and technical reports across numerous sectors including agriculture, education, gender, nutrition, water and sanitation, poverty, trade and global health.

Brad’s cost-benefit research has been used to assist stakeholders to prioritize resources for greatest impact, to make investment cases for increased spending in particular fields and to identify cost-effective approaches to solving development issues. Due to the breadth of his experience, his research increasingly sits at the intersection of development areas, such as systematically reviewing the non-health impacts of vision correction and identifying the poverty and social protection benefits of school feeding programs.

Brad is currently Co-lead Editor on Disease Control Priorities 4, Volume 3: Interventions Outside the Healthcare System, and a Section Editor in Oxford University Press’s Encyclopedia on Water, Sanitation and Global Health, focusing on the economics of water and sanitation investments in low-and-middle-income countries.